Etomidate Injection
Product Images NDC 0143-9310
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Etomidate (NDC 0143-9310). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Hikma Pharmaceuticals Usa Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Logo2 (Etomidate Injection Usp Novaplus 2)
Plb155 (Etomidate Injection Usp Novaplus 3)
This appears to be a description of a medication called Etomidate Injection, USP, with a concentration of 20 mg per 10 mL, which is intended for single-dose use. The manufacturer is "novaplus", and the packaging specifies that it should be stored between 20 and 25 degrees Celsius. There may be additional information related to the proper dosage, but it is not clearly provided.*
Plb156.2 (Etomidate Injection Usp Novaplus 4)
Plb157 (Etomidate Injection Usp Novaplus 5)
Plb158 (Etomidate Injection Usp Novaplus 6)
Etomidate Injection, USP is a sterile and non-pyrogenic solution used for intravenous administration. It is primarily available in single-dose vials with 10% and 20mL capacities. Each mL of the solution contains 2mg of etomidate and 35% propylene glycol. The appropriate dosage for administration should be determined as per the package insert. To open the vial, the user needs to cut along the dotted line provided over the sl. The drug should be stored between 20°C to 25°C (68°F to 77°F). The manufacturer of the drug is HIA Faruaceutir Fortugal.*
Etomidate Injection Usp Novaplus 7
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.